New data backs RiaGev’s ability to bolster cell’s energy machinery, company says

As new evidence comes to the fore and new analytical tools become available, looking at what is happening in the cellular aging process in real time is becoming a real possibility.  In years past looking at the effect of various nutraceuticals in healthy aging relied on cruder measures, such as having subjects respond to questionnaires about how they’re feeling.

One of the key aspects of cellular health is how well the cell’s energy machinery functions.  As that degrades, so do cellular activities of all sorts.  Keeping that machinery functioning as well as possible for as long as possible is the purpose of Bioenergy’s RiaGev ingredient, which was launched in 2019.

Ingredient works on three phases

Michael Crabtree, ND, director of scientific affairs for BioEnergy, said three phases of energy production in the cell are important and involve the CoQ10, glutathione and NAD+ pathways, the latter of which results in the production of ATP, the key energy currency within the cell. 

RiaGev, which was launched in 2019, is a pairing of the company’s patented D-ribose sugar and a coated, extended release nicotinamide ingredient.  Crabtree said new data the company has assembled on the ingredient shows that it has a role to play in all three acts of the cell’s energy play.

“When we started experimenting with this fusion of ribose with nicotinamide, we found that when you put these things together in a specific ratio you got the benefits of all three of these systems being bolstered at the same time,”​ he said.

Source News